| |
|
|
| |
W e l c o m e |
|
| |
| |
|
| |
Dr. Ranjan Duara, MD |
Welcome from Dr. Duara
The annual MCI Symposia in Miami Beach were initiated in 2003 to address the increasing interest in understanding the earliest stages of various disorders that may ultimately lead to dementia. Even though Alzheimer’s disease is the most frequent cause of dementia, many other conditions may accelerate its clinical progression or lead to dementia independently. Experts representing many different disciplines have contributed to the discussions at the MCI Symposia series and the feedback from the audience and the faculty in the last five years has been very positive. We have every reason to believe that you will find the next MCI symposium educational and intellectually stimulating. Please consider attending the Sixth Annual MCI Symposium on March 7 and 8, 2008 in Miami Beach Florida. If you would like more information about the symposium please feel free to contact my assistant, Billy Barker, at info@mcisymposium.com
The Meeting
The purpose of this series of symposia is to provide a forum for new information and for in-depth discussions about advances in Alzheimer's Disease (AD) research, clinical diagnosis and treatment. The goals of the current Mild Cognitive Impairment (MCI) Symposium are to study the pathophysiology of AD and other causes of dementia, and to explore possible methods of intervention in the earliest stages of these disorders, that is, in the MCI stage. We will examine recent developments in understanding disease mechanisms which offer potential strategies for treating and preventing Alzheimer's disease. We will also study methodologies for identifying the earliest stages of the disease as well as assessing the effects of treatment. Finally, we will present results from several studies on potential disease-modifying treatments for Alzheimer's disease that may become available in the future.
The symposium will include a keynote address, a panel discussion, and four individually themed symposia, each featuring national and international experts in the fields of neurology, neurobiology, psychiatry, geriatrics, neuropsychology, radiology, epidemiology and pharmacology. Each mini-symposium will be followed by an extended discussion period, allowing active audience participation to promote a better understanding of the issues.
Upon completion of this symposium, the attendees should have a better understanding of the following:
- Known Risk Factors for Alzheimer's Disease (AD)
- Determinants of the Rate of Progression of AD
- Pathogenic Mechanisms for Cognitive Impairment in Animals and Humans
- Measurement of the Progression and the Effects of Treatment in AD
- Disclosure of the Diagnosis: Why, When and How
- Non-Pharmacological Treatment and Prevention of Early AD and other Dementias
- Potential Disease Modifying Agents for Treatment and Prevention of AD
|
|
| |
|
|
